4DMedical Limited (ASX: 4DX) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
4DMedical Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
4DMedical Limited (ASX: 4DX)
Latest News
Technology Shares
Why these ASX tech stocks could be the next global success stories
Share Fallers
Why 4DMedical, New Hope, Regis Healthcare, and Viva Energy shares are tumbling today
Share Gainers
How this ASX All Ords stock turned $10,000 into $76,521 in just 2 months
Healthcare Shares
Up 787% since July, why is the 4DMedical share price rocketing again today?
Share Fallers
Why 4DMedical, Iluka, Medibank, and Pilbara Minerals shares are sinking today
Share Fallers
Why 4DMedical, BlueScope, EOS, and Spark NZ shares are falling today
Share Gainers
Why 4DMedical, DroneShield, Orthocell, and Resolute Mining shares are racing higher
Share Gainers
Guess which ASX All Ords stock is jumping 29% on big news
Share Market News
Why 4DMedical, Lotus Resources, Vulcan Energy, and Xero shares are storming higher today
Share Gainers
Why 4DMedical, Austal, Iress, and Metallium shares are pushing higher today
Share Gainers
Why 4DMedical, COG, Collins Foods, and Ioneer shares are racing higher
Share Gainers
Guess which ASX All Ords share is rocketing 32% on huge US news
Frequently Asked Questions
-
No, 4DMedical does not pay dividends at this time.
-
4DMedical listed on the ASX on 7 August 2020.
4DX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About 4DMedical Limited
4DMedical Ltd (ASX: 4DX) is a medical technology company working in the field of respiratory imaging and ventilation analysis in the treatment of lung and respiratory diseases.
The company's non-invasive lung imaging technology emanates from research work undertaken at Monash University. It is the first FDA-cleared respiratory imaging solution that uses mathematical models and algorithms to convert sequences of X-ray images into four-dimensional quantitative data.
The technology uses existing imaging systems and allows X-ray images to be taken simultaneously from various angles. Using image-processing methods adapted from aerospace engineering, the motion of lung tissue can be measured. This allows ventilation to be calculated at each stage of the breath and at every location within the lung. These measurements are then visualized as a coloured heat map to help medical professionals accurately identify ventilation deficits.
The 4DMedical technology is patented in key jurisdictions, including the US and Australia. The company is aiming to secure a slice of the global lung imaging market. The US market alone was valued at more than $US30 billion in normal pre-COVID diagnostic conditions.
